MedPath

Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
Interventions
Other: WET sheet Therapeutic body wraps
Other: Dry sheet Therapeutic body wraps
Registration Number
NCT03164746
Lead Sponsor
University Hospital, Lille
Brief Summary

Severe injurious behaviors in children with autism spectrum disorder are challenging. First line treatment approaches include behavioral techniques but pharmacotherapy is frequently required despite frequent adverse effects in youths.

Therapeutic body wraps has been reported in small series or case reports, but has never been assessed in the context of a randomized controlled trial.

The present study is an exploratory, multicenter, randomized, controlled, open label with blinded outcome assessment (PROBE design) trial of the effect of wet versus dry therapeutic body wraps in children presenting with autism spectrum disorder and severe injurious behavior.

Detailed Description

Packing therapy has never been assessed, namely in children with severe injurious behavior and autism spectrum disorder.

The aim of the present study is to evaluate the beneficial effect of wet versus dry therapeutic body wraps through an exploratory randomized controlled open label blinded outcome assessment approach.

The primary objective is the comparison of change in ABC irritability scores from baseline to 3 months between the two groups. According to the potential recruitment, we plan to recruit 30 subjects in each group. This sample size could allow us to detect a minimum effect size of 0.74 between the 2 groups (considered large in literature) with a power of 80% (two-sided test and type I error of 5%).

As described elsewhere, wet or dry session will be organized through twice-a-week sessions for a 3-month duration.

Comparison in primary outcome (ABC irritability score) between the 2 groups will be performed using Analysis of Covariance (ANCOVA) adjusted for the baseline value. The standardized difference (effect size) will be computed taking into account the adjustment for baseline and its 95% confidence interval will be estimated using a bootstrap resampling. The validity of the ANCOVA model will be checked by examining the model residuals.

The same methodology will be used for the secondary outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • a current diagnosis of autism, Asperger syndrome, atypical autism according ICD-10 criteria confirmed by specialized clinical assessment;
  • presenting severe behavioural disturbances such as hetero and self-injurious behaviours, automutilation, severe motor hyperactivity, severe stereotypies.
  • having a systematically consultation by a neuro pediatric.
Exclusion Criteria
  • children with known organic syndrome and/or non-stabilized neuropediatric (e.g. seizures) or medical (e.g. diabetes mellitus) comorbidities.
  • patients with stabilized seizure condition, antiepileptic medication should be stable for at least 4 weeks.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
WET GroupWET sheet Therapeutic body wrapsWet sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.
DRY groupDry sheet Therapeutic body wrapsDry sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.
Primary Outcome Measures
NameTimeMethod
Aberrant Behavior Checklist (ABC) irritability scoreBaseline and 3 months

Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score Irritability of the scale ABC

Secondary Outcome Measures
NameTimeMethod
ABC hyperactivity scoreBaseline,1-month, 2-month and 3-months

Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score hyperactivity of the scale ABC

ABC lethargy scoreBaseline,1-month, 2-month and 3-months

Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score lethargy of the scale ABC

ABC inappropriate speech scoreBaseline,1-month, 2-month and 3-months

Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score inappropriate speech of the scale ABC

ABC stereotypic behavior scoreBaseline,1-month, 2-month and 3-months

Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score stereotypic behavior of the scale ABC

ABC Total scoreBaseline,1-month, 2-month and 3-months

Measure the reduction in the intensity of the behavioral disorders objectified by the total score of the scale ABC

Child Autism Rating Scale (CARS)Baseline,1-month, 2-month and 3-months

Measure the decrease in the intensity of autistic symptoms

Clinical Global Impression-Improvement (CGI-I)Baseline,1-month, 2-month and 3-months

Measure the global clinical outcome

Clinical Global Impression-Severity (CGI-S)Baseline,1-month, 2-month and 3-months

Measure the global clinical outcome

Trial Locations

Locations (13)

Centre de Santé Mentale Angevin

🇫🇷

Angers, France

Centre Hospitalier d'Arras

🇫🇷

Arras, France

Etablissement de Santé Maison Blanche

🇫🇷

Paris, France

Etablissement Public de Santé Roger Prévot

🇫🇷

Gennevilliers, France

Centre Hospitalier de Lens

🇫🇷

Lens, France

Hôpital Fontan, CHRU

🇫🇷

Lille, France

Institut Médico-éducatif

🇫🇷

Montigny-en-Ostrevent, France

Centre Hospitalier Robert Ballanger

🇫🇷

Aulnay-sous-Bois, France

Centre Hospitalier Montfavet

🇫🇷

Avignon, France

Institut Départemental Albert Calmette

🇫🇷

Camiers, France

Etablissement Public de Santé Mentale Val de Lys-Artois

🇫🇷

Saint-Venant, France

Groupe Hospitalier Pitier-Salpêtrière

🇫🇷

Paris, France

Centre Hospitalier de Douai

🇫🇷

Douai, France

© Copyright 2025. All Rights Reserved by MedPath